Abeona Therapeutics Income Statement (2010-2026) | ABEO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & Cost
Revenue (Quarter)
0.00B0.00B0.00B0.00B0.00B0.01B0.01B
Interest income
Interest Income - Total (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Interest expenses
Interest Expense - Others (Quarter)
0.00B
Interest Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Interest Income - Net (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B
Operating Items
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)
0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.00B0.01B0.01B
Selling, General & Administrative (Quarter)
0.01B0.01B0.00B0.00B0.00B0.00B0.01B0.00B0.01B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.02B
Other Operating Expenses (Quarter)
0.00B0.03B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating Expenses (Quarter)
0.01B0.01B0.05B0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.03B
Operating Income (Quarter)
-0.01B-0.01B-0.05B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B0.08B-0.02B
EBIT (Quarter)
-0.01B-0.01B-0.05B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B0.08B-0.02B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Net income details
EBT (Quarter)
-0.02B-0.02B-0.05B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B0.01B-0.03B-0.01B-0.01B0.12B-0.02B-0.02B-0.02B
Tax Provisions (Quarter)
-0.02B-0.00B0.00B
Profit After Tax (Quarter)
-0.02B-0.01B-0.05B-0.02B-0.00B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.03B0.01B-0.03B-0.01B-0.01B0.11B-0.01B-0.02B-0.02B
Income from Continuing Operations (Quarter)
-0.02B-0.02B-0.05B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B0.01B-0.03B-0.01B-0.01B0.12B-0.01B-0.02B-0.02B
Consolidated Net Income (Quarter)
-0.02B-0.02B-0.05B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B0.01B-0.03B-0.01B-0.01B0.12B-0.01B-0.02B-0.02B
Income towards Parent Company (Quarter)
-0.02B-0.02B-0.05B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B0.01B-0.03B-0.01B-0.01B0.12B-0.01B-0.02B-0.02B
Preferred Dividend Payments (Quarter)
0.00B
Net Income towards Common Stockholders (Quarter)
-0.02B-0.01B-0.05B-0.02B-0.01B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.03B-0.01B-0.03B-0.01B-0.01B0.11B-0.01B-0.02B-0.02B
Additional items
EPS (Basic) (Quarter)
-3.93-1.80-11.64-3.801.36-1.000.52-0.54-0.92-0.48-0.64-1.160.19-0.63-0.14-0.242.07-0.10-0.42-0.30
EPS (Weighted Average and Diluted) (Quarter)
1.36-1.000.52-0.54-0.92-0.48-0.64-1.16-0.26-0.63-0.14-0.241.71-0.10-0.34-0.30
Shares Outstanding (Weighted Average) (Quarter)
0.00B0.00B0.00B0.01B0.00B0.00B0.01B0.00B18.02B0.02B0.01B0.00B0.04B0.00B0.04B0.05B0.05B0.05B0.01B0.06B
Shares Outstanding (Diluted Average) (Quarter)
0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.03B0.05B0.04B0.04B0.05B0.07B0.07B0.07B0.06B
EBITDA (Quarter)
-0.02B-0.01B-0.05B-0.02B-0.01B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.03B0.01B-0.03B-0.01B-0.01B0.11B-0.01B-0.02B-0.02B
Tax Rate (Quarter)
74.65%1.04%-0.01%